Refractory medulloblastoma Clinical Trials

Delta Trials indexes 17 clinical trials for Refractory medulloblastoma in its publicly accessible dataset. Of these, 2 enrolling participants at this time and 5 trials have reached completion. This research takes place spanning 159 research sites around the world. An additional 10 trials are in preparatory or other active non-recruiting stages. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.